The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.
from CNN.com - RSS Channel - App International Edition https://ift.tt/1BkSEA3
Saturday, January 7, 2023
Alzheimer's drug lecanemab receives accelerated approval in US amid safety concerns https://ift.tt/JXyuEqL
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment